Clinical Trial Update: Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients [Phase 3]

View source ↗

Summary

Phase 3 pharmacodynamic study comparing PL2200 against enteric-coated and immediate-release aspirin in patients with type 2 diabetes; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Aspirin (Aspirin)
• PL2200

Snippet

Sponsor: PLx Pharma | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-09-04